Imaging Mass Cytometry technology, such as the innovative Hyperion™ Imaging Systems, offers a groundbreaking approach to generating high-dimensional spatial data at subcellular resolution. By utilizing cytometry by time-of-flight, this technology overcomes the limitations of traditional immunohistochemistry and immunofluorescence by using metal-tagged antibodies. This unique method allows for the simultaneous staining, acquisition, and analysis of over 40 markers on a tissue section, free from autofluorescent interference or spectral overlap management. With applications across various tissue types like lung, bone marrow, colon, and brain, Imaging Mass Cytometry technology offers a high-plex imaging solution without compromising data quality. Discover how leading organizations like Navignostics are leveraging spatial proteomics to revolutionize treatment decisions for cancer patients, with rapid reporting within 72 hours of sample receipt. Say goodbye to sequential immunostaining approaches and multiple slide treatment rounds – Imaging Mass Cytometry technology simplifies the workflow by enabling simultaneous staining, acquisition, and visualization of multiple markers.
Tags: spatial proteomics
Read more from standardbio.com